Heparins (UFH and LMWH) and Direct Anti-Xa Oral Anticoagulants are used for the prevention and treatment of thromboembolic diseases. STA Liquid Anti Xa assay The quantitative determination of anti-Xa activity: > of the Heparin (UFH and LMWH) is helpful for monitoring treatment efficacy > of Rivaroxaban, Apixaban or Edoxaban level, in conjunction with clinical examination, is helpful in the assessment of the clinical status in certain situations. 
Click here to download our STA Liquid Anti Xa Brochure STA-ECA II Ecarin chromogenic assay of direct thrombin inhibitors (dabigatran) ECA II Assay Improvement of Ecarin Clotting Time Chromogenic assay Not sensitive to factor II and fibrinogen levels Standardized and fully automated 3 kits: STA – ECA II STA – Dabigatran Calibrator STA – Dabigatran Control Click here for STA ECA II for Dabigatran testing information Heparin Induced Thrombocytopenia Heparin induced thrombocytopenia type II (HIT) is a life-threatening disease associated with exposure to unfractionated or less commonly low-molecular-weight heparin. HIT occurs in up to 5 % of patients on heparin. STiC Expert Lateral Flow Immunoassay to detect IgG antibodies against heparin-PF 4 complexes Asserachrom HPIA-IgG Determination of anti-heparin PF4 antibodies of IgG class by ELISA method Asserachrom HPIA- Polyspecific Determination of anti-heparin PF4 antibodies by ELISA method (IgG, IgM& IgA) 
For more information on HIT testing please click here Other Tools Click here to download a information sheet on the effect of DOACs on routine coagulation assays